Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Somatostatin receptor subtype 1 selective activation in human growth hormone (GH)- and prolactin (PRL)-secreting pituitary adenomas: effects on cell viability, GH, and PRL secretion.
Zatelli MC, Piccin D, Tagliati F, Ambrosio MR, Margutti A, Padovani R, Scanarini M, Culler MD, degli Uberti EC. Zatelli MC, et al. Among authors: piccin d. J Clin Endocrinol Metab. 2003 Jun;88(6):2797-802. doi: 10.1210/jc.2002-021825. J Clin Endocrinol Metab. 2003. PMID: 12788890
Evidence for differential effects of selective somatostatin receptor subtype agonists on alpha-subunit and chromogranin a secretion and on cell viability in human nonfunctioning pituitary adenomas in vitro.
Zatelli MC, Piccin D, Bottoni A, Ambrosio MR, Margutti A, Padovani R, Scanarini M, Taylor JE, Culler MD, Cavazzini L, degli Uberti EC. Zatelli MC, et al. Among authors: piccin d. J Clin Endocrinol Metab. 2004 Oct;89(10):5181-8. doi: 10.1210/jc.2003-031954. J Clin Endocrinol Metab. 2004. PMID: 15472224
Selective activation of somatostatin receptor subtypes differentially modulates secretion and viability in human medullary thyroid carcinoma primary cultures: potential clinical perspectives.
Zatelli MC, Piccin D, Tagliati F, Bottoni A, Luchin A, Vignali C, Margutti A, Bondanelli M, Pansini GC, Pelizzo MR, Culler MD, Degli Uberti EC. Zatelli MC, et al. Among authors: piccin d. J Clin Endocrinol Metab. 2006 Jun;91(6):2218-24. doi: 10.1210/jc.2006-0334. Epub 2006 Mar 28. J Clin Endocrinol Metab. 2006. PMID: 16569735
Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion.
Zatelli MC, Piccin D, Vignali C, Tagliati F, Ambrosio MR, Bondanelli M, Cimino V, Bianchi A, Schmid HA, Scanarini M, Pontecorvi A, De Marinis L, Maira G, degli Uberti EC. Zatelli MC, et al. Among authors: piccin d. Endocr Relat Cancer. 2007 Mar;14(1):91-102. doi: 10.1677/ERC-06-0026. Endocr Relat Cancer. 2007. PMID: 17395978
21 results